Newsletter | February 13, 2026

02.13.26 -- STREAM Edition: BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

SPONSOR

 

 

Join us for February's Bio-Expo Live, a three-day virtual event designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!

Targeting The Fast Lane With Optimized Viral Detection

Video | MilliporeSigma

Once you have your antibody, you are in a race to start manufacturing. Discover a method that allows you to accelerate viral detection by combining the broad range of NGS with the sensitivity of PCR.

From Lab To Commercialization: Simplifying Bioprocess Scale-Up

Webinar | Thermo Fisher Scientific Bioproduction

Explore how cuboid geometries and advanced mixing dynamics create consistent performance from the bench to commercial manufacturing.

 

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

Video | Life Science Leader

On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show during the J.P. Morgan Healthcare Conference, following his departure from LEO Pharma.

What Bioprocessing Professionals Think About An Innovative TFF

Webinar | Repligen

Hear firsthand insights from experts to find out how a TFF system empowers bioprocessing teams—from start-ups to global leaders—with unmatched reliability and flexibility.

Optimize Your Therapy Manufacturing Process Before You Automate

Webinar | Entegris, Inc.

Dive into specific unit operations and case studies that demonstrate how implementing phase appropriate tools can have substantive direct business impacts to cost and development timelines.

AUC As An Alternative For Biologics, Gene Therapy Characterization

Webinar | Coriolis Pharma

Learn how Analytical Ultracentrifugation enables detailed characterization of biologics, vaccines, and gene therapy vectors, offering a powerful alternative for R&D and emerging QC needs.